Side-by-side comparison
Abbott Laboratories vs Medtronic
As of Sep 25, 2026, P/E is 28.4x for Abbott Laboratories vs 21.8x for Medtronic; P/S is 3.9x for Abbott Laboratories vs 3.0x for Medtronic; revenue growth is 6.6% for Abbott Laboratories vs 9.8% for Medtronic; operating margin is 17.1% for Abbott Laboratories vs 18.1% for Medtronic.
Key metrics
| Metric | ABT | MDT |
|---|---|---|
| Price | $101.29 | $88.64 |
| Market cap | $176.43B | $113.38B |
| P/E | 28.4x (#2) | 21.8x (#1) |
| P/S | 3.9x (#2) | 3.0x (#1) |
| Revenue growth | 6.6% (#2) | 9.8% (#1) |
| Operating margin | 17.1% (#2) | 18.1% (#1) |
| Net margin | 13.9% (#2) | 13.9% (#1) |
| Debt / equity | 0.57 (#2) | 0.51 (#1) |
| 1-year return | -24.2% (#2) | -5.9% (#1) |
| Research score | 48/100 (#2) | 61/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Abbott Laboratories (ABT) — Medical Devices
- Medtronic plc (MDT) — Medical Devices